bpc-157 safety human study adverse events BPC-157: Miracle Healing Peptide or Hidden Danger? BPC-157 Side Effects: What Animal
Description
Severe chronic conditions may need 12+ weeks plus ongoing maintenance
The mean apparent clearance of exenatide in humans is 9.1 L/h, and with a half-life of 2.4 h
The safety data is encouraging: no serious adverse events documented across 100+ preclinical studies, no organ damage, and no deaths even at doses 1,000 times typical use (Sikiric et al., 2014
Prez-Reytor D, Jaa V, Pavez L, et al
By covalently bonding DAC to albumin, the compound is able to block peptidase cleavage
